The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development

被引：17
|
作者：
Balasegaram, Manica [1 ]
Piddock, Laura J. V. [1 ]
机构：
[1] Global Antibiot Res & Dev Partnership GARDP, CH-1202 Geneva, Switzerland
来源：
ACS INFECTIOUS DISEASES | 2020年 / 6卷 / 06期
关键词：
D O I：
10.1021/acsinfecdis.0c00101
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The Global Antibiotic Research and Development Partnership (GARDP) brings together public and private partners to accelerate the development and global availability of new antibiotics to treat the most challenging drug-resistant bacterial infections. Established in 2016, GARDP's recently launched strategy sets out its ambitious aim to deliver five new treatments by 2025, focusing on sexually transmitted infections, sepsis in newborns, and infections in hospitalized adults and children.
引用
收藏
页码：1295 / 1298
页数：4
相关论文
共 50 条
  • [21] Development credit corporations: Not-for-profit development finance institutions in the postwar United States
    Koistinen, David
    BUSINESS HISTORY, 2012, 54 (03) : 424 - 440
  • [22] Antibiotic Consumption and the Development of Antibiotic Resistance in Surgical Units
    Tammer, I.
    Geginat, G.
    Lange, S.
    Kropf, S.
    Lodes, U.
    Schlueter, D.
    Lippert, H.
    Meyer, F.
    ZENTRALBLATT FUR CHIRURGIE, 2016, 141 (01): : 53 - 61
  • [23] DEVELOPMENT OF AN ANTIBIOTIC OPTIONS INDEX FOR ANTIBIOTIC RESISTANCE MONITORING
    Manomayitthikan, Taweesuk
    Borlace, Glenn N.
    Kessomboon, Nusaraporn
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2016, 47 (06) : 1288 - 1297
  • [24] Antibiotic resistance and antibiotic development - Author's reply
    Outterson, Kevin
    LANCET INFECTIOUS DISEASES, 2008, 8 (04): : 212 - 214
  • [25] Not-for-profit or for-profit? Research on the high-quality development path of private universities in China based on system dynamics
    Shufen Duan
    Hongjuan Yang
    Fan Ning
    Humanities and Social Sciences Communications, 10
  • [26] Incentivising antibiotic research and development: is the UK's subscription payment model part of the solution?
    Anderson, Michael
    Mossialos, Elias
    LANCET INFECTIOUS DISEASES, 2020, 20 (02): : 162 - 163
  • [27] Not-for-profit or for-profit? Research on the high-quality development path of private universities in China based on system dynamics
    Duan, Shufen
    Yang, Hongjuan
    Ning, Fan
    HUMANITIES & SOCIAL SCIENCES COMMUNICATIONS, 2023, 10 (01):
  • [28] DEVELOPMENT AND USE OF AN ANTIBIOTIC AUDIT AS AN EDUCATIONAL AND SERVICE MODEL
    BROWN, AL
    SUMMERFIELD, MR
    CLINICAL RESEARCH, 1981, 29 (05): : A878 - A878
  • [29] Part I. The Global Antibiotic Resistance Partnership (GARP)
    Winters, C.
    Gelband, H.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2011, 101 (08): : 556 - 557
  • [30] Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization
    Outterson, Kevin
    Rex, John H.
    TRANSLATIONAL RESEARCH, 2020, 220 : 182 - 190
12345